Organized by:
Promega Corporation and the University of Michigan Center for Chemical Genomics
Promega Corporation and the
Emory Chemical Biology Discovery Center

Event Details:*
Friday, March 25, 2011
This event has already occurred, Click Here for photos from the event.
Lecture only: 10:00 a.m. - 12:45 p.m. (Full)
Lecture and lab: 8:30 a.m. - 5:00 p.m. (Full)
Lunch provided

*The lecture and lab are free of charge, however,
registration is required to guarantee your place.

Laboratory Workshop Location:
Emory Chemical Biology Discovery Center
Dental Building
1462 Clifton Rd. NE, Rm 307
Atlanta, GA 30322

Lecture Location:
Emory University
Rollins Research Center
1510 Clifton Rd. NE, Rm 2052
Atlanta, GA 30322

Here is WHAT you'll learn:

  • How to build a powerful cell-based or biochemical assay using bioluminescence detection
  • Hands on practical work to see how reporter gene assays can be used to study cell signaling processes; as an example we will run two different labs:
  • Gene regulation biomarker: measure NfkappaB activation in HEK293 cells
  • Second messenger biomarker: measure cAMP changes via GPCR activation
  • Tips and tricks-of-the-trade for obtaining the most useful data from cell-based reporter assays
  • How to adapt a cell-based assay for high-throughput screening
  • Details of the Emory Chemical Biology Discovery Center (ECBDC), its capabilities and how they could apply to your research
  • Project selection process for submitting HTS and probe design requests to the ECBDC

Agenda: Lecture Only

Time Topic
10:00 – 10:10 am Welcome and Introduction to the Lecture Section:
Haian Fu, Ph.D., Director, Emory Chemical Biology Discovery Center; and Professor of Pharmacology and Hematology/Medical Oncology, Emory University
10:10 – 11:00 am "Using Luminescent Technology to Monitor Key Cell Signaling Biomarkers"
Frank Fan, Ph.D., Director of Research, Promega Corporation
11:00 – 11:40 am "Screening for Small Molecule Modulators at the Emory Chemical Biology Discovery Center"
Yuhong Du, Ph.D., Asssociate Director of HTS and Assay Development, Emory Chemical Biology Discovery Center; and Assistant Professor of Pharmacology, Emory University
11:45 – 12:45 pm Tour of the Emory Chemical Biology Discovery Center
Clinton Maddox, Research Scientist, Emory Chemical Biology Discovery Center, Emory University
11:45 – 12:45 pm Lunch (to be provided)

Agenda: Lecture and Lab

Time Topic
8:30 – 8:45am Introduction & Welcome:
Jeffrey L. Kelly, Ph.D., Strategic Marketing Manager, Cell Analysis, Promega Corporation
8:45 – 10:00am GloResponse NFkappaB Laboratory Activity, Part I
Trista Schagat, Ph.D., Scientific Applications Manager, Promega Corporation; and Adjunct Research Investigator, Department of Biological Chemistry, University of Michigan Medical Center
10:00 – 10:10am Welcome and Introduction to the Lecture Section:
Haian Fu, Ph.D., Director, Emory Chemical Biology Discovery Center; and Professor of Pharmacology and Hematology/Medical Oncology, Emory University
10:10 – 11:00am "Using Luminescent Technology to Monitor Key Cell Signaling Biomarkers"
Frank Fan, Ph.D., Director of Research, Promega Corporation
11:00 – 11:40am "Screening for Small Molecule Modulators at the Emory Chemical Biology Discovery Center"
Yuhong Du, Ph.D., Asssociate Director of HTS and Assay Development, Emory Chemical Biology Discovery Center; and Assistant Professor of Pharmacology, Emory University
11:45 – 12:45pm Tour of the Emory Chemical Biology Discovery Center
Clinton Maddox, Research Scientist, Emory Chemical Biology Discovery Center, Emory University
11:45 – 12:45pm Lunch (to be provided)
12:45 – 1:00pm Introduction to the GloMax®-Multi+ Detection System
1:00 – 2:30pm GloSensor cAMP Laboratory Activity
2:30 – 2:45pm Break
2:45 – 3:30pm GloResponse NFkappaB Laboratory Activity, Part II
3:30 – 3:45pm Break
3:45 – 4:30pm Tips & Techniques: Getting the Most Out of Your Reporter Assays This short seminar covers practical aspects of luciferase reporter assay design and execution. Topics include:
- Reporter design
- Transfection, cell culture & timing considerations
- Appropriate controls
4:30 – 5:00pm Data Analysis Wrap-up of the day’s events

For more information about Promega's Cell-based Assays, please click here.

Questions?

For Promega, contact Jay Hertweck, Field Applications Specialist
Tel: (678) 296-8746
email: jay.hertweck@promega.com

For ECBDC, contact Cheryl Meyerkord, Ph.D., Administrative Project Manager, ECBDC
Tel: (404) 727-4675
email: emory-ncicbc@pharm.emory.edu

 

News

New anti-inflammatory drugs pinch off reactive oxygen species at the source
Cancer Genomics Center, funded by the NCI, targets protein networks for drug discovery
New Class of Potential Drugs Inhibits Inflammation in Brain. --ScienceNews
Chemical Biology Discovery Center hosts workshop on Cell-Based Assays for HTS.
NCI announces Funding the ECBDC for Glioblastoma Multiforme project.
NCI Names Emory to Chemical Biology Consortium

Recent Publications

Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits. Chem Biol. 2012 Jun 22;19(6):752-63.
Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proc Natl Acad Sci USA 2012 Feb 8; Epub Ahead of Press.
Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor. Proc Natl Acad Sci USA 2011 Sep 9; Epub Ahead of Press.
A Novel High Throughput Screening Assay for Discovery of Molecules that Increase Cellular Tetrahydrobiopterin. Journal of Biomolecular Screening [In Press]
A Dual-Readout F2 Assay That Combines Fluorescence Resonance Energy Transfer and Fluorescence Polarization for Monitoring Bimolecular Interactions. ASSAY and Drug Development Technologies. [Epub ahead of print]
Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1046-51. Epub 2010 Dec 29.
Synthesis and Identification of New 4-Arylidene Curcumin Analogues as Potential Anticancer Agents Targeting Nuclear Factor-κB Signaling Pathway. J Med Chem. 2010 Nov 11. [Epub ahead of print]